The Prognostic Values of GDF-15 in Comparison with NT-proBNP in Patients with Normotensive Acute Pulmonary Embolism

Duran L., Kayhan S., Guzel A., Ince M., Katı C., Akdemir H. U., ...Daha Fazla

CLINICAL LABORATORY, cilt.60, sa.8, ss.1365-1371, 2014 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 60 Sayı: 8
  • Basım Tarihi: 2014
  • Doi Numarası: 10.7754/clin.lab.2013.130827
  • Dergi Adı: CLINICAL LABORATORY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1365-1371
  • Anahtar Kelimeler: pulmonary embolism, thrombosis, vascular disease, venous thromboembolism, GROWTH-DIFFERENTIATION FACTOR-15, BRAIN NATRIURETIC PEPTIDE, MACROPHAGE INHIBITORY CYTOKINE-1, RISK STRATIFICATION, SEVERITY INDEX, HEART-FAILURE, MANAGEMENT, DIAGNOSIS, MODEL
  • Ondokuz Mayıs Üniversitesi Adresli: Evet

Özet

Background: An early prediction of prognosis in pulmonary embolism (PE) is a crucial clinical entity. The aim of the study is to investigate whether growth differentiation factor-15 (GDF-15) or N-terminal pro-brain natriuretic peptide levels (NT-proBNP) can better predict the 30 day overall mortality in patients with normotensive acute PE.